Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Ferrari NV (RACE) Price & Performance

Nuvation Bio Inc. Class A Common StockTrade
Ferrari NVTrade

Price performance (Past 24H)

Key statistics

Nuvation Bio Inc. Class A Common Stock vs Ferrari NV — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Ferrari NV trades at $390.29 (market cap $68.13B). The key difference: Ferrari NV is far larger — about 39.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Ferrari NV pays a 1.09% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Ferrari NV for 126 Days on average.

NUVBRACE
Market Cap
$1.71B$68.13B
Volume
5,448,712480,007
Sector
HealthConsumer Cyclical
52-Week High
$9.54$436.54
52-Week Low
$3.41$314.63
Typical Hold Time
0 Days126 Days
Enterprise Value
$1.30B$70.01B
Dividend Yield
—1.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Ferrari NV

Ferrari (RACE) trades at $386.39, down 0.03% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue and net income have grown steadily from 2022 to 2025, supported by robust profitability margins. Recent news highlights a share buyback program and strategic partnerships, while institutional investors show increased interest.

The outlook remains positive due to strong financial performance and analyst consensus, with a price target of $462.75 implying ~20% upside. Risks include high valuation multiples, economic sensitivity, and execution challenges in electric vehicle initiatives. The stock offers growth potential but requires monitoring of competitive and macroeconomic pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NUVB
100% Buy0% Sell
Avg holding period · 0 Days
RACE
0% Buy100% Sell
Avg holding period · 126 Days

Top news

Latest headlines on both assets

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →

About Ferrari NV

Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.

Read more on RACE →